Vimarsana
Biggest News Aggregation in the World

New Medication News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from New Medication. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In New Medication Today - Breaking & Trending Today

Eli Lilly Offers Obesity Drug Directly to Consumers - Vimarsana News

Eli Lilly Offers Obesity Drug Directly to Consumers

Eli Lilly launched its direct-to-patient portal on Thursday, providing its obesity medicine (as well as diabetes and migraine drugs) direct to the consumer.

Diabetes Drug - Tirzepatide Gets FDA Approval for Weight Loss - Vimarsana News

Diabetes Drug - Tirzepatide Gets FDA Approval for Weight Loss

Tirzepatide, a diabetes medication, is approved for weight loss management by FDA and is found to be very beneficial when combined with diet and exercise.

Zurzuvae | FDA approves first postpartum depression pill in the US - Vimarsana News

Zurzuvae | FDA approves first postpartum depression pill in the US

The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.

Zurzuvae | FDA approves first postpartum depression pill in the US - Vimarsana News

Zurzuvae | FDA approves first postpartum depression pill in the US

The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.

Source: abc13.com
First Ever Study of RA Patient Attitudes on Bloodwork to Predict Future Treatment Presented by CreakyJoints - Vimarsana News

First Ever Study of RA Patient Attitudes on Bloodwork to Predict Future Treatment Presented by CreakyJoints

This Study and Others Presented at the EULAR European Congress of Rheumatology 2023 CreakyJoints®, the digital, international patient community for people with all forms of arthritis and part of